Commentary

Why IRRs for healthcare are better than the rest, Permira leads $350m funding in Sysdig

2021 saw record-breaking healthcare deals.

Silver Lake buys into Australian soccer leagues, Ares in talks to acquire ex-Coller execs’ secondaries shop

Ares Management is looking at a second acquisition of a secondaries firm this year.

Clearlake agrees to sell Proven Brands for ~$259m, Arcline founder talks about navigating inflation, supply chain challenges

Clearlake Capital agrees to sell Proven Brands to Hain Celestial Group for about $259 million.

SEC eyes stricter disclosure rules for SPACs; will next year be a sellers' bonanza?

Reforms may be coming around disclosure rules for SPACs.

PE dealmaking approaches record activity this year, Ten Coves leads funding in Cassini Systems

U.S. private equity deal-making to eclipse $1 trillion for the first time this year.

Toshiba walks from $20bn+ buyout deal, Georgian seeks $1.5bn for blind-pool strategy to back prized assets

Georgian unveils blind-pool strategy to continue investing in software assets.

Permira agrees to take-private of Mimecast at $5.8bn valuation, Astara promotes Tannenbaum to partner

Astara ups Tannenbaum to partner and Permira will acquire Mimecast in a take-private deal.

Accel-KKR runs multi-asset secondaries on older fund, JMI Equity leads $85m funding in ServiceTrade

JMI Equity backs ServiceTrade.

Amex Global Business Travel agrees to $5.3bn deal with Apollo SPAC, Carlyle invests in GTCR-backed Resonetics

The merger includes $335 million private investment in public equity (PIPE) financing from new investors; the Carlyle deal continues the firm's focus on medical products businesses.

Post Capital reaps 10x return on EC Waste sale; too much crime in San Fran?

Post Capital made the investment in EC Waste after identifying numerous opportunities in Puerto Rico; anonymous bankers are looking to convince JP Morgan to abandon its annual “Woodstock of Healthcare” conference in San Francisco.